The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127619031 12761903 1 I 20160913 20160920 20160920 EXP PHHY2016BR128134 NOVARTIS 0.00 M Y 64.80000 KG 20160920 OT BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127619031 12761903 1 PS EXELON PATCH RIVASTIGMINE 1 Transdermal 4.6 MG, QD,PATCH 5 (CM2) 092017719130102015 22083 4.6 MG TRANS-THERAPEUTIC-SYSTEM QD
127619031 12761903 2 SS TAMSULOSIN HYDROCHLORIDE. TAMSULOSIN HYDROCHLORIDE 1 Oral 0.4 MG, QD Y 1605383 0 .4 MG TABLET QD
127619031 12761903 3 C DUTASTERIDA 2 Oral 0.5 MG, QD Y 1514301 0 .5 MG TABLET QD
127619031 12761903 4 C RAZAPINA MIRTAZAPINE 1 Oral 30 MG, HALF TABLET FW3760 0 30 MG TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127619031 12761903 1 Memory impairment
127619031 12761903 2 Product used for unknown indication
127619031 12761903 3 Product used for unknown indication
127619031 12761903 4 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
127619031 12761903 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127619031 12761903 Abnormal behaviour
127619031 12761903 Agitation
127619031 12761903 Asthenia
127619031 12761903 Blood pressure decreased
127619031 12761903 Condition aggravated
127619031 12761903 Decreased appetite
127619031 12761903 Drug ineffective
127619031 12761903 Memory impairment
127619031 12761903 Pallor

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found